Allelotyping in mycosis fungoides and Sézary syndrome: Common regions of allelic loss identified on 9p, 10q, and 17p

Journal of Investigative Dermatology

Volumn 117, Issue 3, 2001, Pages 663-670

  Scarisbrick, J J ^a   Woolford, A J ^a   Russell Jones, R ^a   Whittaker, S J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cutaneous T cell lymphoma; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

MICROSATELLITE DNA;

AGE; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 0034787116     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01460.x     Document Type: Article

References (81)

1. Mantle cell lymphomas: A clinicopathological study of 80 cases
2. The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase
3. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: Hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del (12p)
4. Involvement of chromosome 12 and 14 in the cutaneous stage of mycosis fungoides: Cytogenetic evidence for a multistep pathogenesis of the disease
5. Clinical impact of detection of loss of heterozygosity of BRCA 1 and BRCA2 markers in sporadic breast cancer
6. Cytogenetics of T-cell malignant lymphoma: Report of 17 cases and review of the chromosomal breakpoints
7. Characterization of t(2;5) reciprocal transcripts and genomic break points in CD30+ve cutaneous lymphoproliferations
8. Loss of NF 1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
9. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: A cytogenetic analysis with in situ hybridization
10. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas
11. A low rate of loss of heterozygosity is found at many different loci in childhood B-lineage acute lymphocytic leukaemia
12. Bcl-2 protein expression and correlation with the inter-chromosomal 14; 18 translocation in cutaneous lymphoma and pseudolymphoma
13. Localization of a human homolog of the mouse Tiam-1 gene to chromosome 21q22.1
14. Bcl-2 blocks p53 dependent apoptosis
15. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin
16. Karyotype studies of cutaneous T-cell lymphoma: Evidence for clonal origin
17. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription
18. An Alu polymorphism intragenic to the TP53 gene
19. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukaemia
20. Deletions of the cyclin-dependant inhibitor genes p16 and p15 in non-Hodgkin's lymphoma
21. The 1993- 4 Genethon human genetic linkage map
22. Allelotyping analysis of adult T-cell leukaemia
23. Analysis of p18 (INK4C) in adult T-cell leukaemia and non-Hodgkin's lymphoma
24. Detailed mapping of the long arm of chromosome 6 adult T-cell leukaemia
25. Distinct patterns of inactivation of p15 (INK4B) and p16 (INK4A) characterize the major types of hematological malignancies
26. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia
27. Germline p16 mutations in familial melanoma
28. Mutator phenotype in human hematopoietic neoplasms, and its association with deletions disabling DNA repair genes and bcl-2 rearrangements
29. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia
30. Chromosome studies in 17 patients with Sézary syndrome
31. Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods
32. Notable losses at specific regions of chromosome 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization
33. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
34. mRNA expression of Fas receptor (CD95) -associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines
35. The molecular genetics of Philadelphia chromosome-positive leukaemias
36. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: Correlation with the expression of TGF-beta receptors
37. Clinical staging for cutaneous T-cell lymphoma
38. p53 protein expression in cutaneous T-cell lymphomas
39. Chromosome aberrations, spontaneous SCE and growth kinetics in PHA-stimulated lymphocytes in 5 cases of Sézary syndrome
40. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 and Tal-1
41. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
42. Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome
43. p53 tumour suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases
44. p53 immunoreactivity is uncommon in primary cutaneous lymphoma
45. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas
46. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
47. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-beta RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines
48. Allelotype analysis in the evolution of chronic myeloid leukaemia
49. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia
50. Mutational analysis of the PTEN gene in non-Hodgkin's lymphoma
51. p16 gene alterations are frequent in lesions of mycosis fungoides
52. Fingerprinting
53. Clonal characteristics of cutaneous T-cell lymphomas: Cytogenetic evidence from blood, lymph nodes and skin
54. The most common chromosome change in 86 chronic B cell or T cell tumours: A 14q32 translocation
55. 6q Deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma
56. Laboratory methods for the detection of mutations and polymorphisms
57. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial carcinomas
58. Reduced expression of CDKN2a/p16 in mycosis fungoides
59. Molecular analysis of 1p32 genetic involvement in pediatric T-cell non- Hodgkin's lymphoma
60. Expression of p53 and retinoblastoma gene in high grade nodal peripheral T-cell lymphomas
61. Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival
62. Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma
63. TCR gene analysis in the diagnosis of Sézary syndrome
64. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro
65. Loss of heterozygosity on 10q and MSI in primary cutaneous T-cell lymphoma is found in advanced disease and may be associated with homozygous deletion of PTEN
66. Clonal chromosomal abnormalities in cutaneous T-cell lymphoma
67. Cytogenetic studies in 5 patients with Sézary syndrome
68. Allelotyping analysis of childhood acute lymphoplastic leukaemia
69. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukemia
70. Recurring structural chromosomal abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome
71. Chromosome studies in mycosis fungoides
72. p21 (WAF1/CIP1) and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: A p53+, MDM2-, p21- immunophenotype associated with missense p53 mutations
73. Somatic mutations of PTEN in glioblastoma multiforme
74. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality
75. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas
76. Cytogenetic abnormalities in patients with cutaneous T-cell lymphoma
77. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma
78. Analysis of beta, gamma and delta TCR genes in mycosis fungoides and Sézary syndrome
79. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
80. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
81. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumours with and without replication errors